Marketing-authorisation holder · United States
Bdsi
3 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BELBUCA0.075mg base | 0.15mg base | 0.3mg base | 0.45mg base | 0.6mg base | 0.75mg base | 0.9mg base · Film | Buprenorphine | United States | Marketed | 2015 |
| BUNAVAIL2.1mg base; 0.3mg base | 4.2mg base; 0.7mg base | 6.3mg base; 1mg base · Film | Buprenorphine, Naloxone | United States | Not marketed | 2014 |
| SYMPROIC0.2mg base · Tablet | Naldemedine | United States | Marketed | 2017 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 3 | 3 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.